The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-β (Aβ) 40, Aβ42, apolipoprotein E and transthyretin in human cerebrospinal fluid

被引:38
作者
Kunicki, S
Richardson, J
Mehta, PD
Kim, KS
Zorychta, E
机构
[1] McGill Univ, Dept Pathol, Montreal, PQ H3A 2B4, Canada
[2] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
[3] New York State Inst Basic Res Dev Disabil, Dept Immunol, Staten Isl, NY 10314 USA
关键词
aging; Alzheimer's disease; amyloid-beta; apolipoprotein E; cerebrospinal fluid; transthyretin;
D O I
10.1016/S0009-9120(98)00027-7
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: To test whether the concentrations of amyloid-beta (A beta)40, A beta 42, apolipoprotein E (apoE) and transthyretin in the CSF of normal individuals, are linked to three factors which modulate the risk of Alzheimer's disease (AD): chronological age, gender, and the presence of the apoE4 allele. Methods and results: Proteins were measured by enzyme-linked immunosorbent assays except for transthyretin, which was assayed by radial immunodiffusion. The apoE phenotype was determined by isoelectric focusing. While the CSF levels of A beta 42, apoE, and transthyretin are reported to be reduced in AD, we found no relationship between age, gender, or apoE phenotype and the level of any of these proteins in the CSF of nondemented individuals. The concentration of A beta 40 was not modulated by gender or apoE phenotype, but did decline significantly with age. Conclusion: These results indicate that the changes observed in the CSF of AD patients are specific to the disease itself rather than the known risk factors. Copyright (C) 1998 The Canadian Society of Clinical Chemists.
引用
收藏
页码:409 / 415
页数:7
相关论文
共 38 条
[1]   APOLIPOPROTEIN-E ALLELE EPSILON-4 IS LINKED TO INCREASED DEPOSITION OF THE AMYLOID BETA-PEPTIDE (A-BETA) IN CASES WITH OR WITHOUT ALZHEIMERS-DISEASE [J].
BERR, C ;
HAUW, JJ ;
DELAERE, P ;
DUYCKAERTS, C ;
AMOUYEL, P .
NEUROSCIENCE LETTERS, 1994, 178 (02) :221-224
[2]   CEREBROSPINAL-FLUID APOLIPOPROTEIN-E IS REDUCED IN ALZHEIMERS-DISEASE [J].
BLENNOW, K ;
HESSE, C ;
FREDMAN, P .
NEUROREPORT, 1994, 5 (18) :2534-2536
[3]   EPIDEMIOLOGY OF ALZHEIMERS-DISEASE [J].
BRETELER, MMB ;
CLAUS, JJ ;
VANDUIJN, CM ;
LAUNER, LJ ;
HOFMAN, A .
EPIDEMIOLOGIC REVIEWS, 1992, 14 :59-82
[4]   CLINICAL RELEVANCE OF THE QUANTIFICATION OF APOLIPOPROTEIN-E IN CEREBROSPINAL-FLUID [J].
CARLSSON, J ;
ARMSTRONG, VW ;
REIBER, H ;
FELGENHAUER, K ;
SEIDEL, D .
CLINICA CHIMICA ACTA, 1991, 196 (2-3) :167-176
[5]   AN AGE-RELATED CORRELATION BETWEEN LEVELS OF BETA-AMYLOID PRECURSOR PROTEIN AND BETA-AMYLOID IN HUMAN CEREBROSPINAL-FLUID [J].
CARROLL, RT ;
LUST, MR ;
KIM, KS ;
DOYLE, PD ;
EMMERLING, MR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 210 (02) :345-349
[6]   EXCESSIVE PRODUCTION OF AMYLOID BETA-PROTEIN BY PERIPHERAL CELLS OF SYMPTOMATIC AND PRESYMPTOMATIC PATIENTS CARRYING THE SWEDISH FAMILIAL ALZHEIMER-DISEASE MUTATION [J].
CITRON, M ;
VIGOPELFREY, C ;
TEPLOW, DB ;
MILLER, C ;
SCHENK, D ;
JOHNSTON, J ;
WINBLAD, B ;
VENIZELOS, N ;
LANNFELT, L ;
SELKOE, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) :11993-11997
[7]  
Fukumoto H, 1996, AM J PATHOL, V148, P259
[8]   AGE-RELATED-CHANGES IN CEREBROSPINAL-FLUID PROTEIN CONCENTRATIONS [J].
GARTON, MJ ;
KEIR, G ;
LAKSHMI, MV ;
THOMPSON, EJ .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 104 (01) :74-80
[9]   Early-onset dementias: Clinical, neuropathological and genetic characteristics [J].
Giannakopoulos, P ;
Hof, PR ;
Savioz, A ;
Guimon, J ;
Antonarakis, SE ;
Bouras, C .
ACTA NEUROPATHOLOGICA, 1996, 91 (05) :451-465
[10]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890